MindWalk Holdings (FRA:TQB0) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TQB0 MindWalk Holdings Corp FRA:TQB0
43 GF Score
Price €1.19
GF Value €0.85
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is MindWalk Holdings Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:TQB0
43GF Score
MindWalk Holdings Corp FRA:TQB0
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is MindWalk Holdings (FRA:TQB0) Overvalued in 2026?

Based on GuruFocus' analysis, MindWalk Holdings stock appears to be overvalued. The current stock price of €1.19 is trading 40% above its estimated GF Value™ of €0.85. GuruFocus considers MindWalk Holdings to be Significantly Overvalued.

Key valuation signals for FRA:TQB0:

  • Dividends Received:
  • GF Value™: €0.85 vs. price of €1.19 (40% above fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the FRA:TQB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MindWalk Holdings Business Description

Other Exchanges HYFT:USA
Address Industrious 823 Congress Avenue, Suite 300, Austin, TX, USA, 78701
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
43GF Score

Get the complete analysis for FRA:TQB0

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.19
Price
€0.85
GF Value